Abstract
Generalized anxiety disorder, panic disorder with and without agoraphobia, social phobia, and specific phobias are frequently associated with substance use disorders. Since anxiety symptoms may occur as a consequence of withdrawal from drugs such as alcohol, opioids, or benzodiazepines or as a result of intoxication, the differential diagnosis between substance-induced anxiety disorders and comorbid psychiatric disorders can be difficult. Epidemiologic studies indicate a two to threefold increased risk for alcohol use disorders in patients with anxiety disorders; specifically, the prevalence of alcohol dependence but not abuse is increased. The increased risk for substance use can be explained only in part by self-medication or tension reduction. The best option for the treatment of comorbid patients might be standard treatment for substance use plus cognitive–behavioral therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CBT:
-
Cognitive–behavioral therapy
- GAD:
-
Generalized anxiety disorder
- OR:
-
Odds ratio
- PD:
-
Panic disorder
- PTSD:
-
Posttraumatic stress disorder
- SAD:
-
Social anxiety disorder
References
Avants SK, Margolin A, Kosten TR, Rounsaville BJ, Schottenfeld RS (1998) When is less treatment better? The role of social anxiety in matching methadone patients to psychosocial treatments. J Consult Clin Psychol 66(6):924–931
Baldwin DS et al (2014) Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol 28(5):403–439
Ballie A, Sannibal C (2007) Anxiety and drug and alcohol problems. In: Baker A, Velleman R (eds) Clinical handbook of co-existing mental health and drug and alcohol problems. Routledge, London, pp 197–217
Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ, Allgulander C, Vega J (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders—first revision. World J Biol Psychiatry 9(4):248–312. doi:10.1080/15622970802465807
Bishop S, Duncan J, Brett M, Lawrence AD (2004) Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli. Nat Neurosci 7(2):184–188. doi:10.1038/nn1173
Boschloo L, Vogelzangs N, Smit JH, van den Brink W, Veltman DJ, Beekman AT, Penninx BW (2011) Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: findings from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord 131(1–3):233–242. doi:10.1016/j.jad.2010.12.014
Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Veltman DJ, Beekman AT, Penninx BW (2013) Depressive and anxiety disorders predicting first incidence of alcohol use disorders: results of the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry 74(12):1233–1240. doi:10.4088/JCP.12m08159
Brady KT, Sinha R (2005) Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am J Psychiatry 162(8):1483–1493. doi:10.1176/appi.ajp.162.8.1483
Enquist J, Ferwerda M, Madhavan A, Hok D, Whistler JL (2012) Chronic ethanol potentiates the effect of neuropeptides in the basolateral amygdala and shows increased anxiolytic and anti-depressive effects. Neuropsychopharmacology 37(11):2436–2445. doi:10.1038/npp.2012.102
Falk DE, Yi HY, Hilton ME (2008) Age of onset and temporal sequencing of lifetime DSM-IV alcohol use disorders relative to comorbid mood and anxiety disorders. Drug Alcohol Depend 94(1–3):234–245. doi:10.1016/j.drugalcdep.2007.11.022
Farris SG, Epstein EE, McCrady BS, Hunter-Reel D (2012) Do co-morbid anxiety disorders predict drinking outcomes in women with alcohol use disorders? Alcohol Alcohol 47(2):143–148. doi:10.1093/alcalc/agr155
Flensborg-Madsen T, Becker U, Gronbaek M, Knop J, Sher L, Mortensen EL (2011) Alcohol consumption and later risk of hospitalization with psychiatric disorders: prospective cohort study. Psychiatry Res 187(1–2):214–219. doi:10.1016/j.psychres.2010.11.016
George DT, Nutt DJ, Dwyer BA, Linnoila M (1990) Alcoholism and panic disorder: is the comorbidity more than coincidence? Acta Psychiatr Scand 81(2):97–107
Goodwin RD, Stein DJ (2013) Anxiety disorders and drug dependence: evidence on sequence and specificity among adults. Psychiatry Clin Neurosci 67(3):167–173. doi:10.1111/pcn.12030
Grant BF, Goldstein RB, Chou SP, Huang B, Stinson FS, Dawson DA, Compton WM (2009) Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry 14(11):1051–1066. doi:10.1038/mp.2008.41
Grant BF, Hasin DS, Stinson FS, Dawson DA, June Ruan W, Goldstein RB, Huang B (2005) Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med 35(12):1747–1759. doi:10.1017/S0033291705006069
Hintz T, Mann K (2005) Comorbidity in alcohol use disorders: focus on mood, anxiety and personality. In: Rössler W, Stohler R (eds) Dual diagnosis. The evolving conceptual framework. Karger, Basel, pp 65–91
Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):617–627. doi:10.1001/archpsyc.62.6.617
Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC (1997) Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 54(4):313–321
Kushner MG, Mackenzie TB, Fiszdon J, Valentiner DP, Foa E, Anderson N, Wangensteen D (1996) The effects of alcohol consumption on laboratory-induced panic and state anxiety. Arch Gen Psychiatry 53(3):264–270
Liang W, Chikritzhs T, Lenton S (2011) Affective disorders and anxiety disorders predict the risk of drug harmful use and dependence. Addiction 106(6):1126–1134. doi:10.1111/j.1360-0443.2011.03362.x
Marmorstein NR, Iacono WG, Malone SM (2010) Longitudinal associations between depression and substance dependence from adolescence through early adulthood. [Research Support, N.I.H., Extramural]. Drug Alcohol Depend 107(2–3):154–160. doi:10.1016/j.drugalcdep.2009.10.002
Marquenie LA, Schade A, Van Balkom AJ, Koeter M, Frenken S, van den Brink W, van Dyck R (2006) Comorbid phobic disorders do not influence outcome of alcohol dependence treatment. Results of a naturalistic follow-up study. Alcohol Alcohol 41(2):168–173. doi:10.1093/alcalc/agh252
Melchior M, Prokofyeva E, Younès N, Surkan PJ, Martins SS (2014) Treatment for illegal drug use disorders: the role of comorbid mood and anxiety disorders. BMC Psychiatry 14:89. doi:10.1186/1471-244X-14-89
Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, Aguilar-Gaziola S, Kessler RC (1998) Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav 23(6):893–907
Merikangas KR, Zhang H, Avenevoli S, Acharyya S, Neuenschwander M, Angst J (2003) Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich Cohort Study. Arch Gen Psychiatry 60(10):993–1000. doi:10.1001/archpsyc.60.9.993
Norton PJ, Price EC (2007) A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. J Nerv Ment Dis 195(6):521–531
Olatunji BO et al (2010) Efficacy of congnitive behavioural therapy for anxiety disorders: a review of meta-analytic findings. J Psychiatr 33:517–577
Robinson J, Sareen J, Cox BJ, Bolton JM (2011) Role of self-medication in the development of comorbid anxiety and substance use disorders: a longitudinal investigation. [Research Support, Non-U.S. Gov’t]. Arch Gen Psychiatry 68(8):800–807. doi:10.1001/archgenpsychiatry.2011.75
Schade A, Marquenie LA, van Balkom AJ, Koeter MW, de Beurs E, van den Brink W, van Dyck R (2005) The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomized controlled trial. Alcohol Clin Exp Res 29(5):794–800
Schellekens AF, de Jong CA, Buitelaar JK, Verkes RJ (2014) Co-morbid anxiety disorders predict early relapse after inpatient alcohol treatment. Eur Psychiatry. doi:10.1016/j.eurpsy.2013.08.006
Schneier FR, Foosel TE, Hasin DS et al (2010) Social anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and related Conditions. Psychol Med 40:977–988
Schuckit MA, Hesselbrock V (1994) Alcohol dependence and anxiety disorders: what is the relationship? Am J Psychiatry 151(12):1723–1734
Teesson M, Slade T, Mills K (2009) Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. [Research Support, Non-U.S. Gov’t]. Aust N Z J Psychiatry 43(7):606–614. doi:10.1080/00048670902970908
Wüsthoff LE, Waal H, Gråwe RW (2014) The effectiveness of integrated treatment in patients with substance use disorders co-occurring with anxiety and/or depression–a group randomized trial. BMC Psychiatry 14:67. doi:10.1186/1471-244X-14-67
Yang H, Devous MD, Briggs RW, Spence JS, Xiao H, Kreyling N, Adinoff B (2013) Altered neural processing of threat in alcohol-dependent men. Alcohol Clin Exp Res 37(12):2029–2038. doi:10.1111/acer.12187
Yong W, Spence JP, Eskay R, Fitz SD, Damadzic R, Lai D, Liang T (2014) Alcohol-preferring rats show decreased corticotropin-releasing hormone-2 receptor expression and differences in HPA activation compared to alcohol-nonpreferring rats. Alcohol Clin Exp Res 38(5):1275–1283. doi:10.1111/acer.12379
Zimmermann P, Wittchen HU, Hofler M, Pfister H, Kessler RC, Lieb R (2003) Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4-year community study of adolescents and young adults. Psychol Med 33(7):1211–1222
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Soyka, M. (2015). Comorbidity of Anxiety Disorders and Substance Use. In: Dom, G., Moggi, F. (eds) Co-occurring Addictive and Psychiatric Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45375-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-45375-5_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-45374-8
Online ISBN: 978-3-642-45375-5
eBook Packages: MedicineMedicine (R0)